Androgen dynamics in vitro in the human prostate gland. Effect of cyproterone and cyproterone acetate.
Hyperplastic and adenocarcinomatous human prostatic tissue was superfused in vitro with radioactively labelled androst-4-ene-3,17-dione, testosterone and 5alpha-dihydrotestosterone (17beta-hydroxy-5alpha-androstan-3-one), with and without addition of the anti-androgens cyproterone and cyproterone acetate. Cyproterone competitively inhibited the entry of the androgens into the majority of the tissues, whereas cyproterone acetate increased this entry. These findings indicated that transport of androstenedione, testosterone and 5alpha-dihydrotestosterone into prostatic tissue is performed by a specific mechanism, possibly involving a carrier situated in the cell membrane. The extent of metabolism of the three androgens was also modified: formation of 5alpha-dihydrotestosterone from testosterone, and of the latter from androstenedione, was decreased by cyproterone and increased by the acetate. Acetate was more effective than cyproterone in decreasing the ;uptake' of the perfused androgens by the tissue; at the same time, it increased the androgen clearance from the tissue. As cyproterone acetate is the more potent of the two anti-androgens, the possibility that these findings in vitro are related to the different anti-androgenic potency exhibited by the two compounds in vivo is discussed. ;Uptake' of the two anti-androgens and the response to their action on androgen dynamics were similar in adenocarcinomatous and hyperplastic glands.
D000085:Acetates / Q000494:pharmacology; D000368:Aged; D000726:Androgen Antagonists; D000735:Androstenedione / Q000378:metabolism; D001692:Biological Transport; D002247:Carbon Isotopes; D003534:Cyproterone / Q000494:pharmacology; D013196:Dihydrotestosterone / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D011245:Pregnadienes / Q000494:pharmacology*; D011467:Prostate / Q000187:drug effects / Q000378:metabolism*; D011470:Prostatic Hyperplasia / Q000378:metabolism; D013739:Testosterone / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D000085:Acetates; D000726:Androgen Antagonists; D002247:Carbon Isotopes; D011245:Pregnadienes; D013196:Dihydrotestosterone; D014316:Tritium; D013739:Testosterone; D000735:Androstenedione; D003534:Cyproterone